Universal Ibogaine Inc. (TSXV:IBO)

Revenue by Product

Financials in millions CAD. Fiscal year is August - July.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022
Addiction Treatment Clinics and Ibogaine	2.33M
Addiction Treatment Clinics and Ibogaine Growth	126.32%

Revenue by Geography

Financials in millions CAD. Fiscal year is August - July.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022
Canada	2.33M
Canada Growth	126.32%